The Spina Bifida and Hydrocephalus Association of Nigeria (SBHAN) has called on governments at all levels to subsidise drugs and treatment for ...
Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the first new FDA-approved treatment for fibromyalgia in ...